Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Nexus Biosystems acquires Tecan subsidiary REMP

Nexus Biosystems has acquired REMP of Switzerland, a provider of sample management devices, instruments, consumables and software, a wholly-owned subsidiary of the Tecan Group.

With the acquisition, Nexus will be adding to its current operations in the US and Germany the REMP operations in Switzerland, Germany, Japan and the US.

In addition, REMP provides additional R&D, manufacturing, sales and customer support operations in Switzerland and direct sales and customer support in Kawasaki, Japan.

Nexus Biosystems CEO John Lillig said that together, with their new REMP colleagues, they look forward to continuing to provide sample management solutions to their biopharmaceutical, biorepository, diagnostic, forensic, agrochemical and genomic research customers around the world.

“The combined Nexus-REMP resources will strengthen our overall capabilities with expanded first-class service and support for our worldwide customers and a growing pipeline of new product offerings for the growing global sample management community,” Lillig said.